JF
John F. Paolini sold $8.9M of KNSA stock
John F. Paolini, Chief Medical Officer of Kiniksa Pharmaceuticals International, plc (KNSA), sold 96,000 shares of KNSA stock worth $8.9M, per an SEC Form 4 filed Nov 3, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 30, 2026, 4 days before it was made public.
KNSA has moved +7.1% since the trade date, from $92.24 to $98.76 (Nov 9, 2026 close).
- Traded
- Oct 30, 2026
- Disclosed
- Nov 3, 2026
- Filing delay
- 4 days
- Price since
- +7.1%
- Role
- Chief Medical Officer
- Source
- SEC Form 4